In line with these results, ablation of TnC or its effector CCR7 implied inhibition of the lymphoid immune-suppressive stromal properties, reducing tumor progression and metastasis in oral squamous cell carcinoma (64), indicating a relevant approach in the therapy of head and neck tumors. The gene discussed is TNC; the disease is neoplasm.